drugset / Trial / NCT03704181
Colchicine for Patients With Chagas´ Disease( B1 Stage)
Phase 2
Unknown
60 enrolled
University of Sao Paulo General Hospital
Fundação de Amparo à Pesquisa do Estado de São Paulo · collab
RandomizedParallel-groupTriple-blindTreatment
Summary
This study evaluate the addition of colchicine in the treatment of patients with Chagas´disease. Forty patients will receive colchicine while twenty patients will receive placebo
Timeline
- Start
- 2018-10-01
- Primary completion
- 2020-12-30
- Completion
- 2021-01-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Colchicine | Small molecule | 0.5 mg | Oral |